These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 18078392)

  • 1. Diagnosis and treatment of von Willebrand disease: new perspectives and nuances.
    Kessler CM
    Haemophilia; 2007 Dec; 13 Suppl 5():3-14. PubMed ID: 18078392
    [No Abstract]   [Full Text] [Related]  

  • 2. [Inborn and acquired von Willebrand disease].
    Schneppenheim R; Budde U
    Hamostaseologie; 2008 Dec; 28(5):312-9. PubMed ID: 19132162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Re-evaluation of three Israeli families initially diagnosed with type 1 von Willebrand disease in light of the ISTH update on von Willebrand factor pathophysiology and classification.
    Hashemi Soteh SM; Anson J; Inbal A; Peake IR; Goodeve AC
    Haemophilia; 2008 May; 14(3):621-4. PubMed ID: 18384353
    [No Abstract]   [Full Text] [Related]  

  • 4. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.
    Gadisseur A; Berneman Z; Schroyens W; Michiels JJ
    Acta Haematol; 2009; 121(2-3):128-38. PubMed ID: 19506359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. von Willebrand disease, type 2B: A diagnosis more elusive than previously thought.
    Favaloro EJ
    Thromb Haemost; 2008 Mar; 99(3):630-1; author reply 632-3. PubMed ID: 18327414
    [No Abstract]   [Full Text] [Related]  

  • 6. [Inborn and acquired von Willebrand disease].
    Schneppenheim R; Barthels M; Budde U
    Hamostaseologie; 2005 Nov; 25(4):367-75. PubMed ID: 16395486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis of von Willebrand disease subtypes: implications for treatment.
    Budde U
    Haemophilia; 2008 Nov; 14 Suppl 5():27-38. PubMed ID: 18786008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet-type von Willebrand disease and type 2B von Willebrand disease: a story of nonidentical twins when two different genetic abnormalities evolve into similar phenotypes.
    Othman M
    Semin Thromb Hemost; 2007 Nov; 33(8):780-6. PubMed ID: 18175283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical, laboratory and therapeutic aspects of platelet-type von Willebrand disease.
    Franchini M; Montagnana M; Lippi G
    Int J Lab Hematol; 2008 Apr; 30(2):91-4. PubMed ID: 18333841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. von Willebrand disease update: diagnostic and treatment dilemmas.
    Bolton-Maggs PH; Lillicrap D; Goudemand J; Berntorp E
    Haemophilia; 2008 Jul; 14 Suppl 3():56-61. PubMed ID: 18510523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of molecular genetics in diagnosing von Willebrand disease.
    James P; Lillicrap D
    Semin Thromb Hemost; 2008 Sep; 34(6):502-8. PubMed ID: 19085649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotypic identification of platelet-type von Willebrand disease and its discrimination from type 2B von Willebrand disease: a question of 2B or not 2B? A story of nonidentical twins? Or two sides of a multidenominational or multifaceted primary-hemostasis coin?
    Favaloro EJ
    Semin Thromb Hemost; 2008 Feb; 34(1):113-27. PubMed ID: 18393148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autosomal dominant von Willebrand disease type 2M.
    Hermans C; Batlle J
    Acta Haematol; 2009; 121(2-3):139-44. PubMed ID: 19506360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2B or not 2B? Differential identification of Type 2B, versus pseudo-,von Willebrand disease.
    Whalley IN; Perry DJ
    Br J Haematol; 2007 Jan; 136(2):345; author reply 345-6. PubMed ID: 17233824
    [No Abstract]   [Full Text] [Related]  

  • 15. Impact of 789Ala/Ala genotype on quantitative type of von Willebrand disease.
    Ahmad F; Kannan M; Biswas A; Saxena R
    Ann Hematol; 2009 May; 88(5):479-83. PubMed ID: 18923835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of single factor deficiencies: a case study approach.
    Marques MB
    Clin Lab Sci; 2003; 16(2):120-2. PubMed ID: 12757193
    [No Abstract]   [Full Text] [Related]  

  • 17. Time to seek further clarity in the molecular analysis of von Willebrand disease?
    Favaloro EJ
    Thromb Haemost; 2009 Jul; 102(1):175-7. PubMed ID: 19572084
    [No Abstract]   [Full Text] [Related]  

  • 18. [Von Willebrand disease: a common and unrecognized bleeding disorder].
    Boehlen F; Robert-Ebadi H; de Moerloose P
    Rev Med Suisse; 2007 Feb; 3(97):346-50. PubMed ID: 17370733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Managing patients with von Willebrand disease type 1, 2 and 3 with desmopressin and von Willebrand factor-factor VIII concentrate in surgical settings.
    Michiels JJ; van Vliet HH; Berneman Z; Schroyens W; Gadisseur A
    Acta Haematol; 2009; 121(2-3):167-76. PubMed ID: 19506363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Biological diagnosis of Von Willebrand disease and its difficulties].
    Znazen R; Guermazi S; Karoui M
    Tunis Med; 2007 Jun; 85(6):445-9. PubMed ID: 17644894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.